Recombinant preparations of the cytokine interferon (IFN)-α are increasingly used to treat a
number of medical conditions, including chronic viral hepatitis and several malignancies …

Interferon alpha (IFNα) is used for the treatment of several disorders, such as chronic
hepatitis or malignant melanoma. During the therapy, IFNα may cause severe …

Psychiatric disorders or drug addiction are often regarded as contraindications against the
use of interferon alfa (IFN-α) in patients with chronic hepatitis C. Our aim was to obtain …

Background: Psychiatric side‐effects may require dose reduction or premature
discontinuation of interferon therapy in chronic hepatitis C. New strategies are needed in …

Background/Aims: Interferon-alpha (IFN-α) induced depression is a major limitation for the
treatment of chronic hepatitis C, especially for patients with psychiatric disorders. We …

The diagnosis and treatment of children and adolescents with cancer has a tremendous and
lasting effect on the patients, their families, and other individuals in their social network. It …

OBJECTIVE: The aim of the pre-sent study was to investigate the effect of the serotonin
selective reuptake inhibitors (SSRIs) fluoxetine and sertraline and the tricyclic drug …

This study investigated the effect of the serotonin selective reuptake inhibitors (SSRIs)
fluoxetine, sertraline, fluvoxamine and the tricyclic antidepressant (TCA) impiramine on …

Interferon-alpha IFN-α) is a cytokine with strong antiviral and antiproliferative properties. IFN-
α is the only effective treatment for chronic hepatitis C and the first substance that shows …

Symptomatic Treatment of Interferon-α–Induced Depression in... : Journal of Clinical
Psychopharmacology Symptomatic Treatment of Interferon-α–Induced Depression in Hepatitis …